These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16110108)

  • 21. A black umbilicus in a patient with a decompensated liver cirrhosis.
    Smalberg JH; Hendriksz TR; Honkoop P
    Neth J Med; 2016 Dec; 74(10):458. PubMed ID: 27966442
    [No Abstract]   [Full Text] [Related]  

  • 22. Case report: internal and external jugular vein thrombosis with marked accumulation of FDG.
    Kikuchi M; Yamamoto E; Shiomi Y; Nakamoto Y; Shiomi Y; Fujiwara K; Watanabe F; Shinohara S
    Br J Radiol; 2004 Oct; 77(922):888-90. PubMed ID: 15483006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
    Buchmann I; Ganten TM; Haberkorn U
    Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual time point C-11 acetate PET imaging can potentially distinguish focal nodular hyperplasia from primary hepatocellular carcinoma.
    Huo L; Wu Z; Zhuang H; Fu Z; Dang Y
    Clin Nucl Med; 2009 Dec; 34(12):874-7. PubMed ID: 20139820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
    Kong YH; Han CJ; Lee SD; Sohn WS; Kim MJ; Ki SS; Kim J; Jeong SH; Kim YC; Lee JO; Cheon GJ; Choi CW; Lim SM
    Korean J Hepatol; 2004 Dec; 10(4):279-87. PubMed ID: 15613803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma.
    Li S; Beheshti M; Peck-Radosavljevic M; Oezer S; Grumbeck E; Schmid M; Hamilton G; Kapiotis S; Dudczak R; Kletter K
    Liver Int; 2006 Oct; 26(8):920-7. PubMed ID: 16953831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
    Wang XL; Li H; Wang QS; Zhang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
    Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
    Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A well-differentiated hepatocellular carcinoma detected only by F-18 FDG positron emission tomography.
    Krug B; Martinet JP; Lacrosse M; Delos M; Vander Borght T
    Clin Nucl Med; 2003 Jul; 28(7):606-7. PubMed ID: 12819424
    [No Abstract]   [Full Text] [Related]  

  • 30. Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers.
    Jeng LB; Changlai SP; Shen YY; Lin CC; Tsai CH; Kao CH
    Hepatogastroenterology; 2003; 50(54):2154-6. PubMed ID: 14696485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration.
    Nguyen BD
    Clin Nucl Med; 2005 Sep; 30(9):628-9. PubMed ID: 16100488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
    Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
    Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence: A New Pitfall?
    Fidani T; Desmarets G; Goupil J; Pouget JP; Boudousq V
    Clin Nucl Med; 2022 Jul; 47(7):640-643. PubMed ID: 35353745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pylephlebitis and liver abscess mimicking hepatocellular carcinoma.
    Brown KT; Gandhi RT; Covey AM; Brody LA; Getrajdman GI
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):221-5. PubMed ID: 14599973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombectomy before hepatic resection for hepatocellular carcinoma with a tumor thrombus extending to the inferior vena cava.
    Shirabe K; Shimada M; Tsujita E; Maehara S; Yamashita Y; Rikimaru T; Tanaka S; Sugimachi K
    Int Surg; 2001; 86(3):141-3. PubMed ID: 11996069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transumbilical portal catheterization (a study of 120 umbilical portographies)].
    Lavoie P; Legare A; Viallet A
    Rev Int Hepatol; 1967; 17(8):753-68. PubMed ID: 4300500
    [No Abstract]   [Full Text] [Related]  

  • 37. The metabolic spectrum of venous thrombotic disorders found on PET/CT.
    Sopov V; Bernstine H; Stern D; Yefremov N; Sosna J; Groshar D
    AJR Am J Roentgenol; 2009 Dec; 193(6):W530-9. PubMed ID: 19933628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant portal vein thrombosis.
    Aladlouni S; Arrivé L
    Gastroenterol Clin Biol; 2010 Oct; 34(10):508. PubMed ID: 20692781
    [No Abstract]   [Full Text] [Related]  

  • 39. Unusual Tc-99m methylene diphosphonate uptake by clinically suspected adrenal metastases from hepatocellular carcinoma.
    Lin LF; Cheng CY; Hou CH; Shen DH
    Clin Nucl Med; 2011 Dec; 36(12):e207-8. PubMed ID: 22064112
    [No Abstract]   [Full Text] [Related]  

  • 40. FDG PET Findings of Hyperprogression During Immunotherapy in a Patient With Hepatocellular Carcinoma.
    Wang J; Wang X; Yang X; Zhao H; Huo L
    Clin Nucl Med; 2020 Jan; 45(1):92-93. PubMed ID: 31789917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.